Tolerance Inducing Phosphatidylserine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tolerance inducing phosphatidylserine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tolerance Inducing Phosphatidylserine Today - Breaking & Trending Today

Univerity At Buffalo - UB Now: Two UB Researchers Receive Investments From Empire Discovery Institute

Two UB drug development and discovery projects have received investments from the Empire Discovery Institute.
Subscribe
One project focuses on an immunotherapy platform developed by UB pharmacy researcher Sathy Balu-Iyer and his team that could benefit patients who are receiving gene therapy for a variety of diseases. The other will seek to design a therapy for multiple sclerosis (MS) that leverages a novel drug target discovered by a team led by UB medical researcher M. Laura Feltri.
The institute will advance both efforts through its Medicines Discovery Award Program, a competitive incubator and accelerator program designed to identify and advance promising early-stage drug discovery into early proofs of concept. Successful projects will exit the program as either a licensing transaction to a strategic pharmaceutical partner or as an Empire Discovery Institute-created startup company. ....

New York , United States , University Of Rochester , Adam Tulgan , Martin Graham , Ronald Newbold , Sathy Balu Iyer , Satishk Tripathi , M Laura Feltri , Sclerosis International Federation , Roswell Park Comprehensive Cancer Center , Hunter James Kelly Research Institute , Empire Deerfield Discovery Development , Empire Discovery Institute , School Of Pharmacy , Deerfield Management Company , National Multiple Sclerosis Society , Biomedical Sciences , Jacobs School Of Medicine , Tolerance Inducing Phosphatidylserine , Jacobs School , Multiple Sclerosis International Federation , Empire Deerfield Discovery , Roswell Park Comprehensive Cancer , Entrepreneur Partnerships , President Satish ,

Two UB researchers receive investments from Empire Discovery Institute - UB Now: News and views for UB faculty and staff

Two UB drug development and discovery projects have received investments from the Empire Discovery Institute.
One project focuses on an immunotherapy platform developed by UB pharmacy researcher Sathy Balu-Iyer and his team that could benefit patients who are receiving gene therapy for a variety of diseases. The other will seek to design a therapy for multiple sclerosis (MS) that leverages a novel drug target discovered by a team led by UB medical researcher M. Laura Feltri.
The institute will advance both efforts through its Medicines Discovery Award Program, a competitive incubator and accelerator program designed to identify and advance promising early-stage drug discovery into early “proofs of concept.” Successful projects will exit the program as either a licensing transaction to a strategic pharmaceutical partner or as an Empire Discovery Institute-created startup company. ....

New York , United States , University Of Rochester , Adam Tulgan , Martin Graham , Ronald Newbold , Sathy Balu Iyer , Satishk Tripathi , M Laura Feltri , Sclerosis International Federation , Empire Deerfield Discovery Development , Empire Discovery Institute , Deerfield Management Company , Empire State Development , National Multiple Sclerosis Society , Medicines Discovery Award Program , Jacobs School Of Medicine , Roswell Park Comprehensive Cancer Center , Research News , Hunter James Kelly Research Institute , School Of Pharmacy , Biomedical Sciences , Empire Discovery , Empire Discovery Institute Created , Discovery Institute , Roswell Park Comprehensive Cancer ,

Two UB researchers receive investments from Empire Discovery Institute

University at Buffalo
Teams will seek to develop treatment options that could benefit patients with multiple sclerosis, hemophilia and more
BUFFALO, N.Y. Two University at Buffalo drug development and discovery projects have received investments from the Empire Discovery Institute.
One project focuses on an immunotherapy platform developed by UB pharmacy researcher Sathy Balu-Iyer and his team that could benefit patients who are receiving gene therapy for a variety of diseases. The other will seek to design a therapy for multiple sclerosis (MS) that leverages a novel drug target discovered by a team led by UB medical researcher M. Laura Feltri. ....

New York , United States , University Of Rochester , Adam Tulgan , Ronald Newbold , Sathy Balu Iyer , Satishk Tripathi , M Laura Feltri , Sclerosis International Federation , Empire Deerfield Discovery Development , Empire Discovery Institute , Deerfield Management Company , Empire State Development , National Multiple Sclerosis Society , Economic Development , Medicines Discovery Award Program , Jacobs School Of Medicine , Roswell Park Comprehensive Cancer Center , Hunter James Kelly Research Institute , Biomedical Sciences , Ub School Of Pharmacy , University At Buffalo , Empire Discovery , Two University , Empire Discovery Institute Created , Discovery Institute ,